Parsons Capital Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,692
Closed -$304K 365
2017
Q4
$304K Hold
5,692
0.03% 305
2017
Q3
$245K Sell
5,692
-200
-3% -$9.51K 0.03% 330
2017
Q2
$356K Sell
5,892
-1,464
-20% -$86.8K 0.04% 271
2017
Q1
$510K Sell
7,356
-1,400
-16% -$97.2K 0.06% 231
2016
Q4
$584K Hold
8,756
0.08% 207
2016
Q3
$580K Hold
8,756
0.08% 211
2016
Q2
$634K Sell
8,756
-300
-3% -$20.6K 0.09% 205
2016
Q1
$585K Sell
9,056
-36
-0.4% -$2.39K 0.08% 207
2015
Q4
$652K Sell
9,092
-55
-0.6% -$4.07K 0.09% 195
2015
Q3
$702K Buy
9,147
+400
+5% +$32.3K 0.1% 189
2015
Q2
$648K Sell
8,747
-400
-4% -$28.8K 0.09% 210
2015
Q1
$663K Sell
9,147
-99
-1% -$6.88K 0.09% 191
2014
Q4
$611K Sell
9,246
-400
-4% -$24.4K 0.08% 205
2014
Q3
$529K Hold
9,646
0.07% 215
2014
Q2
$561K Sell
9,646
-650
-6% -$38.2K 0.08% 217
2014
Q1
$638K Hold
10,296
0.09% 200
2013
Q4
$550K Sell
10,296
-200
-2% -$10.7K 0.08% 207
2013
Q3
$527K Hold
10,496
0.09% 203
2013
Q2
$481K Buy
+10,496
New +$470K 0.08% 208

Other funds holding MD

Parsons Capital Management's MD Position: Q1 2018 in Review

Parsons Capital Management sold out of Pediatrix Medical (MD) in Q1 2018, closing a stake of 5,692 shares — an estimated $304K sold.

Parsons Capital Management first reported a position in MD in Q2 2013 and held it in 19 quarters. The position peaked at $702K in Q3 2015. 342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

  • Parsons Capital Management reported no remaining Pediatrix Medical position as of Q1 2018 after selling out during the quarter.
  • Parsons Capital Management sold 5,692 Pediatrix Medical shares in Q1 2018, an estimated $304K.
  • Parsons Capital Management first reported a position in Pediatrix Medical in Q2 2013 and held it in 19 quarters.
  • Parsons Capital Management's Pediatrix Medical position peaked at $702K in Q3 2015.
  • 342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on Parsons Capital Management's 13F filing for Q1 2018, filed 7 May 2018.